Company / Tangible Book Value per Share
GYRE THERAPEUTICS, INC. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$1.23
FY2025
5-year range
-$0.25 / $1.86
FY2021-FY2025
Trend
+48.6%
vs FY2024
Sector context
#152 of 209
Health Care
What the data says
At $1.23, GYRE THERAPEUTICS, INC.'s tangible book value per share ranks #152 of 209 in the Health Care sector. Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $-0.25 in FY2023 to $20.63 in FY2016.
Based on SEC 10-K filings.
1.23 in FY2025 with a 5-year CAGR of -26.4%.
Improved from $-0.25 to $1.23 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +8.8%
- 5-Year CAGR
- -26.4%
- 10-Year CAGR
- -
Sector benchmark
-99.0% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 48.6% year-over-year.
- Ranks #152 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2016.
- Lowest tangible book value per share in the period was in FY2023.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.23 | +48.6% |
| FY2024 | $0.83 | +432.1% |
| FY2023 | -$0.25 | -126.1% |
| FY2022 | $0.95 | -48.7% |
| FY2021 | $1.86 | -67.2% |
| FY2020 | $5.68 | -0.7% |
| FY2019 | $5.72 | +13.0% |
| FY2018 | $5.06 | -43.7% |
| FY2017 | $8.99 | -56.4% |
| FY2016 | $20.63 | -80.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026